Dong-a St Co., Ltd.

This study tests whether adding a new drug called DA-2811 to standard diabetes medications helps lower blood sugar more effectively in people with type 2 diabetes. About 288 adults with poorly controlled diabetes will receive either DA-2811 or a placebo alongside their usual trea…

This study tests a new medicine called DA-5218 for people with type 2 diabetes whose blood sugar is not well controlled with metformin alone. About 238 adults will receive either DA-5218 or an active comparator to see how well it lowers HbA1c (a measure of blood sugar over time) …

This study aims to see if two versions of a drug, DA-5230 and DA-5230-R, are absorbed and processed by the body in the same way. It involves 60 healthy adults aged 19 to 55 who will receive a single dose of each version on separate days. The results will help determine if the two…